Owens & Minor Inc. Stock
€23.00
Your prediction
Owens & Minor Inc. Stock
Pros and Cons of Owens & Minor Inc. in the next few years
Pros
Cons
Performance of Owens & Minor Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Owens & Minor Inc. | 1.770% | 0.000% | 16.162% | 91.667% | 31.429% | -25.783% | - |
Orasure Tech | -3.170% | -6.870% | -3.175% | 0.826% | -18.121% | -34.054% | -40.371% |
scPharmaceuticals | 7.000% | 13.347% | 3.883% | -20.741% | -6.957% | -6.957% | - |
SI-BONE Inc | - | -9.375% | -24.870% | 23.932% | -23.684% | -45.076% | - |
Comments
News
Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023.
Full Year 2023 Key Highlights:
-
Consolidated revenue of $10.3 billion
Owens & Minor Announces Fourth Quarter 2023 Earnings Release Date and Conference Call
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the fourth quarter of 2023 on Tuesday, February 20, 2024, before trading begins on the New York Stock Exchange.
The Company
Owens & Minor Unveils Long-Term Strategy at Investor Day Today
Owens & Minor, Inc. (NYSE-OMI) (the “Company”), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product